Literature DB >> 33099480

Comparison of Benign and Malignant Pilomatricomas Using Whole-exome Sequencing.

Min-Kyung Yeo1, Go Eun Bae2.   

Abstract

BACKGROUND: Malignant pilomatricoma (MP) is a rare cancer of the hair matrix with only a few cases reported in literature. Given the rarity of this cancer and the lack of relevant genetic data, very little is known about the nature of the molecular pathophysiology except the involvement of the Catenin Beta 1 (CTNNB1)/Wnt/β-catenin signaling pathway in some cases.
MATERIALS AND METHODS: We describe the whole-exome genomic profiling of four samples from two patients: 1) an MP from patient I, 2) a coexisting benign pilomatricoma (BP) from patient I, 3) a BP from an age and location-matched control patient II, and 4) normal skin tissue from patient II.
RESULTS: We detected a pathogenic somatic missense mutation in fibroblast growth factor receptor 4 (FGFR4) (c.1162G>A, p. Gly388Arg) in MP and coexisting BP in patient I, whereas the control BP harbored the classical CTNNB1 mutant.
CONCLUSION: This study, the first comparative analysis of benign and MP through whole-exome analysis, identified a novel oncogenic mutation in FGFR4. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CTNNB1; FGFR4; malignant; mutation; pilomatricoma; whole-exome sequencing

Mesh:

Substances:

Year:  2020        PMID: 33099480      PMCID: PMC7675647          DOI: 10.21873/cgp.20233

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  28 in total

1.  beta-Catenin gene mutation in human hair follicle-related tumors.

Authors:  Y Kajino; A Yamaguchi; N Hashimoto; A Matsuura; N Sato; K Kikuchi
Journal:  Pathol Int       Date:  2001-07       Impact factor: 2.534

2.  Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.

Authors:  Frederik Marmé; Thomas Hielscher; Sarah Hug; Sandra Bondong; Robert Zeillinger; Dan Cacsire Castillo-Tong; Jalid Sehouli; Ioana Braicu; Ignace Vergote; Cadron Isabella; Sven Mahner; Irmgard Ferschke; Joachim Rom; Christof Sohn; Andreas Schneeweiss; Peter Altevogt
Journal:  Int J Cancer       Date:  2012-01-31       Impact factor: 7.396

3.  Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.

Authors:  Magdalena Chmara; Annekatrin Wernstedt; Bartosz Wasag; Hilde Peeters; Marleen Renard; Eline Beert; Hilde Brems; Tina Giner; Imke Bieber; Henning Hamm; Raf Sciot; Katharina Wimmer; Eric Legius
Journal:  Genes Chromosomes Cancer       Date:  2013-04-30       Impact factor: 5.006

Review 4.  UV signature mutations.

Authors:  Douglas E Brash
Journal:  Photochem Photobiol       Date:  2014-11-28       Impact factor: 3.421

5.  Mutations in exon 3 of the CTNNB1 gene (beta-catenin gene) in cutaneous adnexal tumors.

Authors:  Dmitry V Kazakov; Radek Sima; Tomas Vanecek; Heinz Kutzner; Gabriele Palmedo; Denisa Kacerovska; Petr Grossmann; Michal Michal
Journal:  Am J Dermatopathol       Date:  2009-05       Impact factor: 1.533

6.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

Authors:  D E Brash; J A Rudolph; J A Simon; A Lin; G J McKenna; H P Baden; A J Halperin; J Pontén
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.

Authors:  S Streit; D S Mestel; M Schmidt; A Ullrich; C Berking
Journal:  Br J Cancer       Date:  2006-05-23       Impact factor: 7.640

8.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

9.  A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency.

Authors:  Katharina Wimmer; Andreas Beilken; Rainer Nustede; Tim Ripperger; Britta Lamottke; Benno Ure; Diana Steinmann; Tanja Reineke-Plaass; Ulrich Lehmann; Johannes Zschocke; Laura Valle; Christine Fauth; Christian P Kratz
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

10.  Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype.

Authors:  Albert Rübben; Renate Ursula Wahl; Thomas Eggermann; Edgar Dahl; Nadina Ortiz-Brüchle; Claudio Cacchi
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

View more
  1 in total

1.  No Evidence of Abnormal Expression of Beta-Catenin and Bcl-2 Proteins in Pilomatricoma as One Clinical Feature of Tetrasomy 9p Syndrome.

Authors:  Chariyawan Charalsawadi; Sasipong Trongnit; Kanoot Jaruthamsophon; Juthamas Wirojanan; Somchit Jaruratanasirikul; Anupong Nitiruangjaras; Pornprot Limprasert
Journal:  Int J Pediatr       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.